SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Arrieta A, Maruri N, Rinon M, Fernandez JR, Ortiz de Urbina J, Garcia Masdevall MD. Confirmation of graft-versus-host disease by HLA typing after liver transplantation. Transplant Proc 2002; 34: 278279.
  • 2
    Au WY, Ma SK, Kwong YL, Ng IO, Hawkins BR, Wan TS, et al. Graft-versus-host disease after liver transplantation: documentation by fluorescent in situ hybridisation and human leucocyte antigen typing. Clin Transplant 2000; 14: 174177.
  • 3
    Aziz H, Trigo P, Lendoire J, Bianco G, Saul J, Braslavsky G, et al. Successful treatment of graft-vs-host disease after a second liver transplant. Transplant Proc 1998; 30: 28912892.
  • 4
    Bhaduri BR, Tan KC, Humphreys S, Williams R, Donaldson P, Vergani D, et al. Graft-versus-host disease after orthotopic liver transplantation in a child. Transplant Proc 1990; 22: 23782380.
  • 5
    Burdick JF, Vogelsang GB, Smith WJ, Farmer ER, Bias WB, Kaufmann SH, et al. Severe graft-versus-host disease in a liver-transplant recipient. N Engl J Med 1988; 318: 689691.
  • 6
    Burt M, Jazwinska E, Lynch S, Kerlin P, Gill D, Steadman C, et al. Detection of circulating donor deoxyribonucleic acid by microsatellite analysis in a liver transplant recipient. Liver Transpl Surg 1996; 2: 391394.
  • 7
    Cattral MS, Langnas AN, Wisecarver JL, Harper JC, Rubocki RJ, Bynon JS, et al. Survival of graft-versus-host disease in a liver transplant recipient. Transplantation 1994; 57: 12711274.
  • 8
    Collins RH Jr, Cooper B, Nikaein A, Klintmalm G, Fay JW. Graft-versus-host disease in a liver transplant recipient. Ann Intern Med 1992; 116: 391392.
  • 9
    Collins RH Jr, Anastasi J, Terstappen LW, Nikaein A, Feng J, Fay JW, et al. Brief report: donor-derived long-term multilineage hematopoiesis in a liver-transplant recipient. N Engl J Med 1993; 328: 762765.
  • 10
    Comenzo RL, Malachowski ME, Rohrer RJ, Freeman RB, Rabson A, Berkman EM. Anomalous ABO phenotype in a child after an ABO-incompatible liver transplantation. N Engl J Med 1992; 326: 867870.
  • 11
    Connors J, Drolet B, Walsh J, Crosby DL, Esterly NB. Morbilliform eruption in a liver transplantation patient. Arch Dermatol 1996; 132: 11611163.
  • 12
    DePaoli AM, Bitran J. Graft-versus-host disease and liver transplantation. Ann Intern Med 1992; 117: 170171.
  • 13
    Dunn SP, Krueger LJ, Butani L, Punnett H. Late onset of severe graft-versus-host disease in a pediatric liver transplant recipient. Transplantation 2001; 71: 14831485.
  • 14
    Gulbahce HE, Brown CA, Wick M, Segall M, Jessurun J. Graft-vs-host disease after solid organ transplant. Am J Clin Pathol 2003; 119: 568573.
  • 15
    Hahn AB, Baliga P. Rapid method for the analysis of peripheral chimerism in suspected graft-versus-host disease after liver transplantation. Liver Transpl 2000; 6: 180184.
  • 16
    Jamieson NV, Joysey V, Friend PJ, Marcus R, Ramsbottom S, Baglin T, et al. Graft-versus-host disease in solid organ transplantation. Transpl Int 1991; 4: 6771.
  • 17
    Joseph JM, Mosimann F, Tiercy JM, Roux E, Cerottini JP, Gillet M, et al. PCR confirmation of microchimerism and diagnosis of graft versus host disease after liver transplantation. Transpl Int 1999; 12: 468470.
  • 18
    Joysey VC, Wood H, Ramsbottom S, Morgan H, Ford C, Horsford J, et al. Lymphocyte chimaerism after organ transplantation. Transplant Proc 1992; 24: 25192522.
  • 19
    Kiuchi T, Harada H, Matsukawa H, Kasahara M, Inomata Y, Uemoto S, et al. One-way donor-recipient HLA-matching as a risk factor for graft-versus-host disease in living-related liver transplantation. Transpl Int 1998; 11( Suppl 1): S383S384.
  • 20
    Kuball J, Theobald M, Ferreira EA, Hess G, Burg J, Maccagno G, et al. Control of organ transplant–associated graft-versus-host disease by activated host lymphocyte infusions. Transplantation 2004; 78: 17741779.
  • 21
    Lehner F, Becker T, Sybrecht L, Luck R, Schwinzer R, Slateva K, et al. Successful outcome of acute graft-versus-host disease in a liver allograft recipient by withdrawal of immunosuppression. Transplantation 2002; 73: 307310.
  • 22
    Marubayashi S, Matsuzaka C, Takeda A, Costa MM, Jamieson NV, Joysey V, et al. Fatal generalized acute graft-versus-host disease in a liver transplant recipient. Transplantation 1990; 50: 709711.
  • 23
    Mazzaferro V, Andreola S, Regalia E, Poli F, Doci R, Bozzetti F, et al. Confirmation of graft-versus-host disease after liver transplantation by PCR HLA-typing. Transplantation 1993; 55: 423425.
  • 24
    Neumann UP, Kaisers U, Langrehr JM, Muller AR, Blumhardt G, Bechstein WO, et al. Fatal graft-versus-host-disease: a grave complication after orthotopic liver transplantation. Transplant Proc 1994; 26: 36163617.
  • 25
    Pageaux GP, Perrigault PF, Fabre JM, Portales P, Souche B, Dereure O, et al. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism. Clin Transplant 1995; 9: 6569.
  • 26
    Paizis G, Tait BD, Kyle P, Angus PW, Grigg AP. Successful resolution of severe graft versus host disease after liver transplantation correlating with disappearance of donor DNA from the peripheral blood. Aust N Z J Med 1998; 28: 830832.
  • 27
    Pinna AD, Weppler D, Berho M, Masetti M, DeFaria W, Kato T, et al. Unusual presentation of graft-versus-host disease in pediatric liver transplant recipients: evidence of late and recurrent disease. Pediatr Transplant 1999; 3: 236242.
  • 28
    Pollack MS, Speeg KV, Callander NS, Freytes CO, Espinoza AA, Esterl RM, et al. Severe, late-onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis. Hum Immunol 2005; 66: 2831.
  • 29
    Redondo P, Espana A, Herrero JI, Quiroga J, Cienfuegos JA, Azanza JR, et al. Graft-versus-host disease after liver transplantation. J Am Acad Dermatol 1993; 29: 314317.
  • 30
    Ricordi C, Tzakis AG, Zeevi A, Rybka WB, Demetris AJ, Fontes PA, et al. Reversal of graft-versus-host disease with infusion of autologous bone marrow. Cell Transplant 1994; 3: 187192.
  • 31
    Rinon M, Maruri N, Arrieta A, Fernandez JR, Ortiz de Urbina J, Garcia Masdevall MD. Selective immunosuppression with daclizumab in liver transplantation with graft-versus-host disease. Transplant Proc 2002; 34: 109110.
  • 32
    Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, et al. Graft vs host disease after liver transplantation in humans: a report of four cases. Hepatology 1991; 14: 274281.
  • 33
    Rosen CB, Ng CS, Moore SB, Batts KP, Santrach PJ, Noel P, Wiesner RH, et al. Clinical and pathological features of graft-versus-host disease after liver transplantation; a case report and review of the literature. Clin Transplant 1993; 7: 5258.
  • 34
    Romagnuolo J, Jewell LD, Kneteman NM, Bain VG. Graft-versus-host disease after liver transplantation complicated by systemic aspergillosis with pancarditis. Can J Gastroenterol 2000; 14: 637640.
  • 35
    Sanchez-Izquierdo JA, Lumbreras C, Colina F, Martinez-Laso J, Jimenez C, Gomez R, et al. Severe graft versus host disease following liver transplantation confirmed by PCR–HLA-B sequencing: report of a case and literature review. Hepatogastroenterology 1996; 43: 10571061.
  • 36
    Schmuth M, Vogel W, Weinlich G, Margreiter R, Fritsch P, Sepp N. Cutaneous lesions as the presenting sign of acute graft-versus-host disease following liver transplantation. Br J Dermatol 1999; 141: 901904.
  • 37
    Schrager JJ, Vnencak-Jones CL, Graber SE, Neff AT, Chari RS, Wright KJ Jr, et al. Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients. Transplantation 2006; 81: 2125.
  • 38
    Smith DM, Agura E, Netto G, Collins R, Levy M, Goldstein R, et al. Liver transplant–associated graft-versus-host disease. Transplantation 2003; 75: 118126.
  • 39
    Soejima Y, Shimada M, Suehiro T, Hiroshige S, Gondo H, Takami A, et al. Graft-versus-host disease following living donor liver transplantation. Liver Transpl 2004; 10: 460464.
  • 40
    Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 11271152.
  • 41
    Sudhindran S, Taylor A, Delriviere L, Collins VP, Liu L, Taylor CJ, et al. Treatment of graft-versus-host disease after liver transplantation with basiliximab followed by bowel resection. Am J Transplant 2003; 3: 10241029.
  • 42
    Taylor AL, Gibbs P, Sudhindran S, Key T, Goodman RS, Morgan CH, et al. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation. Transplantation 2004; 77: 441446.
  • 43
    Walling HW, Voigt MD, Stone MS. Lichenoid graft vs host disease following liver transplantation. J Cutan Pathol 2004; 31: 179184.
  • 44
    Whitington PF, Rubin CM, Alonso EM, McKeithan TW, Anastasi J, Hart J, et al. Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor. Transplantation 1996; 62: 15161519.
  • 45
    Whalen JG, Jukic DM, English JC 3rd. Rash and pancytopenia as initial manifestations of acute graft-versus-host disease after liver transplantation. J Am Acad Dermatol 2005; 52: 908912.
  • 46
    Hanaway MJ, Buell JF, Musat AI, Kalayoglu M. Graft-versus-host disease in solid organ transplantation. Graft 2001; 4: 205208.
  • 47
    Anderson KC, Weinstein HJ. Transfusion-associated graft-versus-host disease. N Engl J Med 1990; 323: 315321.
  • 48
    Billingham R. The biology of graft-versus-host reactions. Harvey Lect 1966–1967; 62: 2178.
  • 49
    Taylor AL, Gibbs P, Bradley JA. Acute graft versus host disease following liver transplantation: the enemy within. Am J Transplant 2004; 4: 466474.
  • 50
    Van Bekkem D. Transfusion or transplantation? Isr J Med Sci 1965; 1: 879882.
  • 51
    Norris S, Collins C, Doherty DG, Smith F, McEntee G, Traynor O, et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 1998; 28: 8490.
  • 52
    Domiati-Saad R, Klintmalm GB, Netto G, Agura ED, Chinnakotla S, Smith DM. Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism. Am J Transplant 2005; 5: 29682973.
  • 53
    Bombi JA, Nadal A, Carreras E, Ramirez J, Munoz J, Rozman C, et al. Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease. Am J Clin Pathol 1995; 103: 690695.
  • 54
    Deeg HJ, Loughran TP Jr, Storb R, Kennedy MS, Sullivan KM, Doney K, et al. Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone. Transplantation 1985; 40: 162166.
  • 55
    Doney KC, Weiden PL, Storb R, Thomas ED. Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids. Am J Hematol 1981; 11: 18.
  • 56
    Khoury H, Kashyap A, Adkins DR, Brown RA, Miller G, Vij R, et al. Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin. Bone Marrow Transplant 2001; 27: 10591064.
  • 57
    Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, et al. A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. Blood 1990; 76: 14641472.
  • 58
    McCaul KG, Nevill TJ, Barnett MJ, Toze CL, Currie CJ, Sutherland HJ, et al. Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin. J Hematother Stem Cell Res 2000; 9: 367374.
  • 59
    Przepiorka D, Kernan NA, Ippoliti C, Papadopoulos EB, Giralt S, Khouri I, et al. Daclizumab, a humanized anti–interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease. Blood 2000; 95: 8389.
  • 60
    Cuthbert RJ, Phillips GL, Barnett MJ, Nantel SH, Reece DE, Shepherd JD, et al. Anti–interleukin-2 receptor monoclonal antibody (BT 563) in the treatment of severe acute GVHD refractory to systemic corticosteroid therapy. Bone Marrow Transplant 1992; 10: 451455.
  • 61
    Anasetti C, Martin PJ, Hansen JA, Appelbaum FR, Beatty PG, Doney K, et al. A phase I–II study evaluating the murine anti–IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease. Transplantation 1990; 50: 4954.
  • 62
    Herve P, Wijdenes J, Bergerat JP, Bordigoni P, Milpied N, Cahn JY, et al. Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti–interleukin-2 receptor monoclonal antibody (B-B10). Blood 1990; 75: 10171023.
  • 63
    Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 14391441.
  • 64
    Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006; 81: 13901397.